1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Holly LaFon
Holly LaFon
Articles (5749) 

Invesco European Growth Fund Comments on MorphoSys

November 11, 2013 | About:

MorphoSys (XTER:MOR) is a German biotechnology company with a proprietary technology to develop human antibodies for specific diseases. The company signed two licensing deals (with GlaxoSmithKline PLC and Celgene Corp.) for its proprietary compounds, providing outside validation for its technology as well as upfront cash and future royalty payments.

From Invesco European Growth Fund’s third quarter 2013 commentary.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus Mobile App


User Generated Screeners


apliszkaInsider >$5
blohmventurespetrovski score and earnings p
daftheadergreat cap allocator
kirk2% Div Growth
BoKraTest
rael2222ribasso 1
Nelson HsuAlphabet Scores
parjo628Momentum
dpostelBEST VAL W SECTORS
dpostelBEST VAL WITH SECTORS

Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK